A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

Clinical trial NCT01419925 · COMPLETED

Trial details

NCT number: NCT01419925
Sponsor: BiondVax Pharmaceuticals ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Healthy

Start date: 2011-08-01
Primary completion: 2012-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.